Literature DB >> 34839123

Does inflammation mediate the effects of depression on heart disease? That may depend on the symptoms.

Robert M Carney1, Kenneth E Freedland2.   

Abstract

Preparation of this manuscript was supported in part by grant number R01HL089336 from the National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, Maryland USA, Robert M. Carney.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Heart disease; Inflammation

Year:  2021        PMID： 34839123      PMCID： PMC9126995          DOI： 10.1016/j.jpsychores.2021.110683

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN： 0022-3999            Impact factor:   4.620


  25 in total

1.  Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

Authors:  J P Empana; D H Sykes; G Luc; I Juhan-Vague; D Arveiler; J Ferrieres; P Amouyel; A Bingham; M Montaye; J B Ruidavets; B Haas; A Evans; X Jouven; P Ducimetiere
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

Review 2.  Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression.

Authors:  Yuri Milaneschi; Femke Lamers; Michael Berk; Brenda W J H Penninx
Journal:  Biol Psychiatry       Date:  2020-01-28       Impact factor: 13.382

Review 3.  Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis.

Authors:  R de Miranda Azevedo; A M Roest; P W Hoen; P de Jonge
Journal:  Psychol Med       Date:  2014-01-27       Impact factor: 7.723

Review 4.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

Review 5.  Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Authors:  Andrew H Miller; Vladimir Maletic; Charles L Raison
Journal:  Biol Psychiatry       Date:  2009-01-15       Impact factor: 13.382

6.  Major depression, C-reactive protein, and incident ischemic heart disease in healthy men and women.

Authors:  Paul G Surtees; Nicholas W J Wainwright; S Matthijs Boekholdt; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw
Journal:  Psychosom Med       Date:  2008-08-25       Impact factor: 4.312

7.  Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms.

Authors:  Eleonora Iob; Clemens Kirschbaum; Andrew Steptoe
Journal:  Mol Psychiatry       Date:  2019-08-21       Impact factor: 15.992

Review 8.  Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications.

Authors:  Michael J Lucido; Mandy Bekhbat; David R Goldsmith; Michael T Treadway; Ebrahim Haroon; Jennifer C Felger; Andrew H Miller
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 25.468

9.  Treatment-resistant depression and peripheral C-reactive protein.

Authors:  Samuel R Chamberlain; Jonathan Cavanagh; Peter de Boer; Valeria Mondelli; Declan N C Jones; Wayne C Drevets; Philip J Cowen; Neil A Harrison; Linda Pointon; Carmine M Pariante; Edward T Bullmore
Journal:  Br J Psychiatry       Date:  2018-05-16       Impact factor: 9.319

10.  Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing.

Authors:  Samantha Lawes; Panayotes Demakakos; Andrew Steptoe; Glyn Lewis; Livia A Carvalho
Journal:  Psychol Med       Date:  2018-09-17       Impact factor: 7.723
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.